Back to Atlas
CTransientStandard research/education caution
CMP-0446
Supplement/OTC-adjacent
Salicin
Anti-inflammatory
Analgesic and anti-inflammatory support
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Nutraceutical / glycoside
- Primary mechanism
- Salicylate prodrug pathway
- Primary market use
- Pain / inflammation
Pharmacology
- Molecular weight (Da)
- 286.3
- Oral bioavailability
- Oral; converted to salicylate
- Half-life
- ~2-3 h salicylate
- Route tags
- Route-dependent / verify
- Evidence level
- Traditional/Human
- Clinical status
- Supplement/OTC-adjacent
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Requires ongoing dosing; pharmacologic anti-inflammatory effect